# TRAVERE THERAPEUTICS, INC. (TVTX) FY2026 YTD Q2 Statement of Cash Flows

- Company: TRAVERE THERAPEUTICS, INC. (TVTX)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-04, accession number 0001438533-26-000063
- Page: https://plicit.ai/financials/tvtx/fy2026-ytd-q2-cash-flow
- Chart image: https://plicit.ai/charts/tvtx-fy2026-ytd-q2-cash-flow-sankey.png

## Chart details

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Dec 31, 2025**: 93,035,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- **Operating activities**: 17,705,000 US dollars. Net cash provided.
- **Net loss from continuing operations**: negative 71,399,000 US dollars
- **Depreciation and amortization**: 29,446,000 US dollars
- **Share based compensation**: 37,934,000 US dollars
- **Foreign currency remeasurement impact**: 950,000 US dollars
- **Inducement expense**: 40,008,000 US dollars
- **Other**: negative 2,614,000 US dollars
- **Accounts receivable**: negative 583,000 US dollars
- **Inventory**: negative 3,450,000 US dollars
- **Prepaid expenses and other current and non-current assets**: negative 9,457,000 US dollars
- **Accounts payable**: negative 17,211,000 US dollars
- **Accrued expenses**: 9,194,000 US dollars
- **Deferred revenue**: 0 US dollars
- **Other current and non-current liabilities**: 4,887,000 US dollars
- **Investing activities**: negative 184,738,000 US dollars. Net cash used.
- **Proceeds from the sale and maturity of marketable debt securities**: 85,149,000 US dollars
- **Purchase of marketable debt securities**: negative 226,638,000 US dollars
- **Purchase of intangible assets**: negative 43,249,000 US dollars
- **Other**: 0 US dollars
- **Financing activities**: 191,721,000 US dollars. Net cash provided.
- **Payment of guaranteed minimum royalty**: negative 1,050,000 US dollars
- **Proceeds from issuance of 2032 convertible senior notes**: 525,000,000 US dollars
- **Payment of debt issuance costs**: negative 16,270,000 US dollars
- **Repurchase of 2029 convertible senior notes including premium**: negative 350,885,000 US dollars
- **Proceeds from exercise of stock options**: 32,570,000 US dollars
- **Proceeds from issuances under the employee stock purchase plan**: 2,356,000 US dollars
- **Operating adjustment reconciliation**: 122,419,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing gross reconciliation**: 559,926,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing gross reconciliation**: 269,887,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **Exchange-rate effect**: 12,000 US dollars
- **Ending cash on Jun 30, 2026**: 117,735,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- **Cash sources and uses**: 302,473,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: 24,700,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: Unavailable. Operating cash flow and reconciliation net income for the same period are required.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$71.40M + net operating adjustments $89.10M = operating cash +$17.71M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.